Dr. Jeffrey GlennonRadboud University Medical Centre

Donders Institute for Brain, Cognition and Behaviour,Nijmegen, The Netherlands.

1

2

2013: The year of change

FP7

Horizon 2020

2013

Research agenda FP7 health

Formerly there was a procedure for an annual workprogramme:

•Reflection paper

•Roadmap

•Concept Workprogramme

•Published call

•This will now change to support three different but overlapping 3 year workprogrammes

3

Relevant difference FP7 vs H2020 with respect toprogramming in time

WP 2008 WP 2009 WP 2010 WP 2011 WP 2012 WP 2013KP7

H2020 WP 2014 WP 2015 WP 2016

WP 2016 WP 2017 WP 2018

WP 2018 WP 2020WP 2019

WP 2007

Year 1 Year 2 Year 4 Year 5 Year 6 Year 7Year 3

Year 1 Year 2 Year 4 Year 5 Year 6 Year 7Year 3

Strategic Programme 1

Strategic Programme 3

Strategic Programme 2

Strategic Programme: focus areas in general terms for

period of 3 years

4

5

FP7 – National delegates Programme Committee Health

Expert group (National funding agencies + National contact points)

Sounding board group + Liaison network

6

Influence

Europe:

•Project coordinators – scientific officers

•Workshops and Conferences EC

•Scientific advisory board

Nationally:

•Digital Liaison network: comments to Concept work programmes

7

Horizon 2020

• Proposed by European Commission:

• Four Programme Committees:

• 1. Better Society Health, Demographic change and Wellbeing

• 2. Competitive industries

• 3. Excellent science

• 4. Horizontal crosscutting issues

• European Council (Member states): 17 Program committees

• European Parliament: 4 working groups

8

Future points of contact

• Project coordinators – scientific officers

• Workshops and conferences particularly on H2020 topics organized by the EU and national ministries.

• National delegate programme committee (Liaison group)

FP7 vs HORIZON 2020

Research Policy

DG Research

DG InfoSoc

Enterprise Policy

DG Enterprise

DG TREN

Education Policy

DG Education

Regional Policy

DG Region

Health Policy

DG SANCO

DG InfoSoc

2007-2013

FP7 (€ 50 bln)

CIP (€ 3.6 bln)

EIT (€ 0.4 bln)

Structural Funds for Innovation (€ 86 bln)

European Innovation Partnership (pilot)

EU TREATIES

HORIZON 2020

(€ 65 – 100 bln?)

2014-2020

Other EU Funding:

E4all, Cohesion, etc

Joint Programming

Co

mm

on

Fu

nd

ing

Ru

les

9

Across all FP7 domains: top 10 in termsof granted budget

COUNTRYgranted

budget (M€)Return %

1. Germany 4.024 16,4%

2. United Kingdom 3.508 14,3%

3. France 2.858 11,7%

4. Italy 2.057 8,4%

5. Spain 1.721 7,0%

6. Netherlands 1.635 6,7%

7. Switserland 1.096 4,5%

8. Belgium 960 3,9%

9. Sweden 957 3,9%

10. Austria 650 2,7%

10

Across all FP7 domains: top 10 in termsof number of projects

COUNTRY

No of granted projects with

country participation2

007

Succes rate

1. United Kingdom 5.937 20,9%

2. Germany 5.303 20,0%

3. France 4.402 22,3%

4. Italy 3.877 16,4%

5. Spain 3.695 18,7%

6. Netherlands 3.009 23,2%

7. Belgium 2.223 22,1%

8. Switserland 2.075 23,6%

9. Sweden 1.930 21,4%

10. Greece 1.603 15,8%

11

FP7 - HEALTH: top 10 in terms of granted budget

COUNTRYgranted

budget (M€)Return %

1. United Kingdom 532,8 16,9%

2. Germany 512,3 16,2%

3. France 331,1 10,5%

4. Netherlands 283,4 9,0%

5. Italy 236,5 7,5%

6. Sweden 173,2 5,5%

7. Spain 164,7 5,2%

8. Switserland 140,0 4,4%

9. Belgium 120,3 3,8%

10. Denmark 89,2 2,8%

12

FP7 - HEALTH: top 10 in termsof number of projects

COUNTRY

No of grantedprojects with

country participationfrom 2007

Succes rate

1. United Kingdom 525 23,4%

2. Germany 495 22,6%

3. France 385 24,7%

4. Italy 342 18,7%

5. Netherlands 340 26,1%

6. Spain 268 21,2%

7. Sweden 243 26,1%

8. Switserland 233 25,8%

9. Belgium 231 25,8%

10. Denmark 143 25,2%

13

Trends in funding:

• decrease in national funding budget:

• government earnings on natural gas no longer available for funding of research

• development of Topsector policy – potential still unclear / uncertain for Radboud UMC

• increase in European funding budget …

• ambition European Commision and European Parliament: strong increase in budget for

Research & Innovation in H2020

• European Council: some Member States wanted very significant budget cuts, even to

(or below) current level of FP7

14

Trends in programming:

• increase in joint programming of national research

programmes

• to avoid unwanted fragmentation or ineffectiveness

• to effectively tackle societal challenges

• increase in joint technology initiatives

• to achieve greater strategic focus

• combining a critical mass of national, European and private resources

15

Structure of Horizon 2020

• Excellent Science: € 27.8 bln

• ERC (77% increase in budget!)

• Future and Emerging Technologies (FET; ICT incubator)

• Marie Curie Actions

• Research Infrastructures

• Industrial Leadership: € 20.3 bln

• Leadership in Key Enabling and industrial Technologies (KET)

• Innovation in SME’s

• Access to Risk Finance

• Societal Challenges: € 35.9 bln

16

Societal challenges

• Health, Demographic Change and Well-being

• € 9 bln of which € 500 mln for EIT

• Food Security and Bio-based Economy

• Secure, Clean and Efficient Energy

• Smart, Green and Integrated Transport

• Climate Change, Resource Efficiency and Raw Materials

• Freedom and Security

• Inclusive, Innovative and Secure Societies

17

Health, demographic change and wellbeing (proposed)

• Understanding the determinants of health, improving health promotion and disease prevention

• Developing effective screening programmes and improving the assessment of disease susceptibility

• Improving surveillance and preparedness

• Understanding disease

• Developing better vaccines

• Improving diagnosis

• Using in-silico medicine for improving disease management and prediction

• Treating disease

18

Health, demographic change and wellbeing (proposed)

• Transferring knowledge to clinical practice and scalable innovation actions

• Better use of health data

• Improving scientific tools and methods to support policy making and regulatory needs

• Active ageing, independent and assisted living

• Individual empowerment for self-management of health

• Promoting integrated care

• Optimising the efficiency and effectiveness of healthcare systems and reducing inequalities through evidence based decision making and dissemination of best practices and innovative technologies and approaches

• Specific implementation aspects

19

Health, demographic change and wellbeing (proposed)

Description level example “Understanding disease”:

“There is a need for an improved understanding of health and disease, in people of all ages, so that new and better prevention measures, diagnosis and treatments can be developed. Interdisciplinary, translational research on the patho-physiology of disease is essential to improve the understanding of all aspects of disease processes, including a re-classification of normal variation and disease based on molecular data, and to validate and use research results in clinical applications.

Underpinning research will encompass and encourage development and use of new tools and approaches for the generation of biomedical data and include "-omics", high throughput and systems medicine approaches. These activities will demand close linkage between fundamental and clinical research and with long term cohort studies (and the corresponding research domains) as described above. Close links with research and medical infrastructures (databases, bio-banks etc.) will also be required, for standardisation, storage, sharing and access to data, which are all essential for maximising data utility and for stimulating more innovative and effective ways of analysing and combining datasets.”

20

Health, demographic change and wellbeing (proposed)

Description level example “Improving diagnosis”:

“An improved understanding of health, disease and disease processes at all ages is needed to

develop new and more effective diagnostics. Innovative and existing technologies will be

developed with the goal of significantly improving disease outcomes through earlier, more

accurate diagnosis and by allowing for more patient-adapted treatment.”

21

Draft work-programmein circulation

First calls announced December 2013 / January 2014.

22